Increase/Decrease in Cash: The total change in cash for the company over the given period.
Lakewood-Amedex Biotherapeutics Inc. (LABT) had Increase/Decrease in Cash of $2.35M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.90M |
|
-- |
|
-- |
|
$3.79M |
|
$-3.79M |
|
$0.02M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.77M |
|
$-3.79M |
|
$-3.76M |
|
1.42M |
|
1.42M |
|
$-2.75 |
|
$-2.75 |
|
| Balance Sheet Financials | |
$4.85M |
|
$0.01M |
|
$0.11M |
|
$4.96M |
|
$0.63M |
|
-- |
|
-- |
|
$0.63M |
|
$4.33M |
|
$4.33M |
|
$4.33M |
|
2.17M |
|
| Cash Flow Statement Financials | |
$-2.45M |
|
$-2.00M |
|
$6.80M |
|
$0.24M |
|
$2.58M |
|
|
Increase/Decrease in Cash |
$2.35M |
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-87.09% |
|
-87.09% |
|
-76.05% |
|
-87.09% |
|
$2.00 |
|
$-1.73 |
|
$-1.73 |
|